-
1
-
-
34948887646
-
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
-
Val-HeFT Investigators
-
Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242-1249.
-
(2007)
Circulation.
, vol.116
, pp. 1242-1249
-
-
Latini, R.1
Masson, S.2
Anand, I.S.3
Missov, E.4
Carlson, M.5
Vago, T.6
Angelici, L.7
Barlera, S.8
Parrinello, G.9
Maggioni, A.P.10
Tognoni, G.11
Cohn, J.N.12
-
2
-
-
84866400461
-
Troponin elevation in patients with heart failure: On behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
-
Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33:2265-2271.
-
(2012)
Eur Heart J.
, vol.33
, pp. 2265-2271
-
-
Januzzi, J.L.1
Filippatos, G.2
Nieminen, M.3
Gheorghiade, M.4
-
3
-
-
77957204899
-
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications
-
Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;56:1071-1078.
-
(2010)
J Am Coll Cardiol.
, vol.56
, pp. 1071-1078
-
-
Kociol, R.D.1
Pang, P.S.2
Gheorghiade, M.3
Fonarow, G.C.4
O'connor, C.M.5
Felker, G.M.6
-
4
-
-
6444239869
-
Ongoing myocardial injury in stable severe heart failure: Value of cardiac troponin T monitoring for high-risk patient identification
-
Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, Pitzus AE, Garcia EH, Obregón R, Brizuela M, Barbagelata A. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation. 2004;110:2376-2382.
-
(2004)
Circulation.
, vol.110
, pp. 2376-2382
-
-
Perna, E.R.1
Macin, S.M.2
Canella, J.P.3
Augier, N.4
Stival, J.L.5
Cialzeta, J.R.6
Pitzus, A.E.7
Garcia, E.H.8
Obregón, R.9
Brizuela, M.10
Barbagelata, A.11
-
5
-
-
7044233456
-
Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction
-
Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest. 2004;64:667-676.
-
(2004)
Scand J Clin Lab Invest.
, vol.64
, pp. 667-676
-
-
Löwbeer, C.1
Gustafsson, S.A.2
Seeberger, A.3
Bouvier, F.4
Hulting, J.5
-
6
-
-
84896141366
-
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: Results from the CORONA trial
-
CORONA Study Group
-
Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J; CORONA Study Group. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circ Heart Fail. 2014;7:96-103.
-
(2014)
Circ Heart Fail.
, vol.7
, pp. 96-103
-
-
Gravning, J.1
Askevold, E.T.2
Nymo, S.H.3
Ueland, T.4
Wikstrand, J.5
McMurray, J.J.6
Aukrust, P.7
Gullestad, L.8
Kjekshus, J.9
-
7
-
-
84856106687
-
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: Data from 2 large randomized clinical trials
-
Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Investigators
-
Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R; Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Investigators. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Circulation. 2012;125:280-288.
-
(2012)
Circulation.
, vol.125
, pp. 280-288
-
-
Masson, S.1
Anand, I.2
Favero, C.3
Barlera, S.4
Vago, T.5
Bertocchi, F.6
Maggioni, A.P.7
Tavazzi, L.8
Tognoni, G.9
Cohn, J.N.10
Latini, R.11
-
8
-
-
84868589495
-
Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: A report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study
-
Perna ER, Aspromonte N, Cimbaro Canella JP, Di Tano G, Macin SM, Feola M, Coronel ML, Milani L, Parras JI, Milli M, García EH, Valle R. Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study. J Card Fail. 2012;18:822-830.
-
(2012)
J Card Fail.
, vol.18
, pp. 822-830
-
-
Perna, E.R.1
Aspromonte, N.2
Cimbaro Canella, J.P.3
Di Tano, G.4
Macin, S.M.5
Feola, M.6
Coronel, M.L.7
Milani, L.8
Parras, J.I.9
Milli, M.10
García, E.H.11
Valle, R.12
-
9
-
-
79959819123
-
High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction? A cross-sectional study
-
Dinh W, Nickl W, Füth R, Lankisch M, Hess G, Zdunek D, Scheffold T, Barroso MC, Tiroch K, Ziegler D, Seyfarth M. High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study. BMC Cardiovasc Disord. 2011;11:41.
-
(2011)
BMC Cardiovasc Disord.
, vol.11
, pp. 41
-
-
Dinh, W.1
Nickl, W.2
Füth, R.3
Lankisch, M.4
Hess, G.5
Zdunek, D.6
Scheffold, T.7
Barroso, M.C.8
Tiroch, K.9
Ziegler, D.10
Seyfarth, M.11
-
10
-
-
69049107557
-
Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function
-
Shah RV, Chen-Tournoux AA, Picard MH, Januzzi JL. Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function. Eur J Echocardiogr. 2009;10:765-768.
-
(2009)
Eur J Echocardiogr.
, vol.10
, pp. 765-768
-
-
Shah, R.V.1
Chen-Tournoux, A.A.2
Picard, M.H.3
Januzzi, J.L.4
-
11
-
-
3843094224
-
Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle
-
Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953-1959.
-
(2004)
N Engl J Med.
, vol.350
, pp. 1953-1959
-
-
Zile, M.R.1
Baicu, C.F.2
Gaasch, W.H.3
-
12
-
-
83155192115
-
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction
-
I-PRESERVE Investigators
-
Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE; I-PRESERVE Investigators. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501.
-
(2011)
Circulation.
, vol.124
, pp. 2491-2501
-
-
Zile, M.R.1
Gottdiener, J.S.2
Hetzel, S.J.3
McMurray, J.J.4
Komajda, M.5
McKelvie, R.6
Baicu, C.F.7
Massie, B.M.8
Carson, P.E.9
-
13
-
-
84893321088
-
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction
-
PARAMOUNT Investigators
-
Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD; PARAMOUNT Investigators. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014;63:447-456.
-
(2014)
J Am Coll Cardiol.
, vol.63
, pp. 447-456
-
-
Kraigher-Krainer, E.1
Shah, A.M.2
Gupta, D.K.3
Santos, A.4
Claggett, B.5
Pieske, B.6
Zile, M.R.7
Voors, A.A.8
Lefkowitz, M.P.9
Packer, M.10
McMurray, J.J.11
Solomon, S.D.12
-
14
-
-
84867745957
-
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial
-
Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators
-
Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012;380:1387-1395.
-
(2012)
Lancet.
, vol.380
, pp. 1387-1395
-
-
Solomon, S.D.1
Zile, M.2
Pieske, B.3
Voors, A.4
Shah, A.5
Kraigher-Krainer, E.6
Shi, V.7
Bransford, T.8
Takeuchi, M.9
Gong, J.10
Lefkowitz, M.11
Packer, M.12
McMurray, J.J.13
-
15
-
-
84871927704
-
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: Correlation with outcomes
-
RELAX-AHF Investigators
-
Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld L, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Prescott MF, Edwards C, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin T, Teerlink JR; RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol. 2013;61:196-206.
-
(2013)
J Am Coll Cardiol.
, vol.61
, pp. 196-206
-
-
Metra, M.1
Cotter, G.2
Davison, B.A.3
Felker, G.M.4
Filippatos, G.5
Greenberg, B.H.6
Ponikowski, P.7
Unemori, E.8
Voors, A.A.9
Adams, K.F.10
Dorobantu, M.I.11
Grinfeld, L.12
Jondeau, G.13
Marmor, A.14
Masip, J.15
Pang, P.S.16
Werdan, K.17
Prescott, M.F.18
Edwards, C.19
Teichman, S.L.20
Trapani, A.21
Bush, C.A.22
Saini, R.23
Schumacher, C.24
Severin, T.25
Teerlink, J.R.26
more..
-
16
-
-
29244432482
-
Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
-
Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography
-
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
-
(2005)
J Am Soc Echocardiogr.
, vol.18
, pp. 1440-1463
-
-
Lang, R.M.1
Bierig, M.2
Devereux, R.B.3
Flachskampf, F.A.4
Foster, E.5
Pellikka, P.A.6
Picard, M.H.7
Roman, M.J.8
Seward, J.9
Shanewise, J.S.10
Solomon, S.D.11
Spencer, K.T.12
Sutton, M.S.13
Stewart, W.J.14
-
17
-
-
35348837803
-
B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart
-
Burley DS, Baxter GF. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart. Basic Res Cardiol. 2007;102:529-541.
-
(2007)
Basic Res Cardiol.
, vol.102
, pp. 529-541
-
-
Burley, D.S.1
Baxter, G.F.2
-
18
-
-
57349142933
-
Irbesartan in patients with heart failure and preserved ejection fraction
-
I-PRESERVE Investigators
-
Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-2467.
-
(2008)
N Engl J Med.
, vol.359
, pp. 2456-2467
-
-
Massie, B.M.1
Carson, P.E.2
McMurray, J.J.3
Komajda, M.4
McKelvie, R.5
Zile, M.R.6
Anderson, S.7
Donovan, M.8
Iverson, E.9
Staiger, C.10
Ptaszynska, A.11
-
19
-
-
33746088001
-
Trends in prevalence and outcome of heart failure with preserved ejection fraction
-
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259.
-
(2006)
N Engl J Med.
, vol.355
, pp. 251-259
-
-
Owan, T.E.1
Hodge, D.O.2
Herges, R.M.3
Jacobsen, S.J.4
Roger, V.L.5
Redfield, M.M.6
-
20
-
-
79954631118
-
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study
-
Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011;123:1367-1376.
-
(2011)
Circulation.
, vol.123
, pp. 1367-1376
-
-
Saunders, J.T.1
Nambi, V.2
De Lemos, J.A.3
Chambless, L.E.4
Virani, S.S.5
Boerwinkle, E.6
Hoogeveen, R.C.7
Liu, X.8
Astor, B.C.9
Mosley, T.H.10
Folsom, A.R.11
Heiss, G.12
Coresh, J.13
Ballantyne, C.M.14
-
21
-
-
84870556584
-
What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?
-
Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol. 2012;60:2349-2356.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 2349-2356
-
-
Campbell, R.T.1
Jhund, P.S.2
Castagno, D.3
Hawkins, N.M.4
Petrie, M.C.5
McMurray, J.J.6
-
22
-
-
0028786990
-
Stretch-induced programmed myocyte cell death
-
Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
-
(1995)
J Clin Invest.
, vol.96
, pp. 2247-2259
-
-
Cheng, W.1
Li, B.2
Kajstura, J.3
Li, P.4
Wolin, M.S.5
Sonnenblick, E.H.6
Hintze, T.H.7
Olivetti, G.8
Anversa, P.9
-
23
-
-
0037423671
-
Myocyte death, growth, and regeneration in cardiac hypertrophy and failure
-
Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res. 2003;92:139-150.
-
(2003)
Circ Res.
, vol.92
, pp. 139-150
-
-
Nadal-Ginard, B.1
Kajstura, J.2
Leri, A.3
Anversa, P.4
-
24
-
-
38649092437
-
Release of cardiac troponin i from viable cardiomyocytes is mediated by integrin stimulation
-
Hessel MH, Atsma DE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch. 2008;455:979-986.
-
(2008)
Pflugers Arch.
, vol.455
, pp. 979-986
-
-
Hessel, M.H.1
Atsma, D.E.2
Van Der Valk, E.J.3
Bax, W.H.4
Schalij, M.J.5
Van Der Laarse, A.6
-
25
-
-
84886644443
-
Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy
-
Kawasaki T, Sakai C, Harimoto K, Yamano M, Miki S, Kamitani T. Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013;112:867-872.
-
(2013)
Am J Cardiol.
, vol.112
, pp. 867-872
-
-
Kawasaki, T.1
Sakai, C.2
Harimoto, K.3
Yamano, M.4
Miki, S.5
Kamitani, T.6
-
26
-
-
84876806120
-
High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertension
-
Völkers M, Rohde D, Zelniker T, Weiss CS, Giannitsis E, Katus HA, Meyer FJ. High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertension. BMC Pulm Med. 2013;13:28.
-
(2013)
BMC Pulm Med.
, vol.13
, pp. 28
-
-
Völkers, M.1
Rohde, D.2
Zelniker, T.3
Weiss, C.S.4
Giannitsis, E.5
Katus, H.A.6
Meyer, F.J.7
-
27
-
-
79952829685
-
Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment
-
Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670-679.
-
(2011)
Eur Heart J.
, vol.32
, pp. 670-679
-
-
Borlaug, B.A.1
Paulus, W.J.2
-
28
-
-
84901983713
-
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: An analysis of the PARAMOUNT trial
-
Jhund PS, Claggett B, Packer M, Zile MR, Voors AA, Pieske B, Lefkowitz M, Shi V, Bransford T, McMurray JJ, Solomon SD. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. Eur J Heart Fail. 2014;16:671-677.
-
(2014)
Eur J Heart Fail.
, vol.16
, pp. 671-677
-
-
Jhund, P.S.1
Claggett, B.2
Packer, M.3
Zile, M.R.4
Voors, A.A.5
Pieske, B.6
Lefkowitz, M.7
Shi, V.8
Bransford, T.9
McMurray, J.J.10
Solomon, S.D.11
|